Potential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patients.

Mezlocillin was used as an initial empiric antibiotic therapy for febrile (> 101 degrees F, ca. 38.33 degrees C) granulocytopenic (< 1,000/microliter) cancer patients. Patients known to be colonized with an organism resistant to 100 micrograms of mezlocillin per mol were excluded. The initial...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Antimicrob Agents Chemother
Auteurs principaux: Wade, J C, Schimpff, S C, Newman, K A, Fortner, C L, Moody, M R, Young, V M, Wiernik, P H
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology (ASM) 1980
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC283987/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6449902/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.18.2.299
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires